CSL Limited

CSL Limited is a global biotechnology leader that develops and delivers innovative medicines to treat people with life-threatening medical conditions. The company operates through three primary business units: CSL Behring, which focuses on plasma-derived and recombinant protein therapies; CSL Seqirus, the world's second-largest influenza vaccine provider; and CSL Vifor, a specialist in iron deficiency and nephrology. Founded in 1916 as the Commonwealth Serum Laboratories, CSL has evolved from a government-owned entity into a multinational powerhouse. It maintains a vast global network of plasma collection centers (CSL Plasma) and state-of-the-art manufacturing facilities across Australia, Europe, and the United States, serving patients in more than 100 countries.